# FDA 483 - Daniel H. Ahn D.O. - September 22, 2023

Source: https://www.keypedia.com/records/483/daniel-h-ahn-do/e5af01fc-16e3-480e-8355-68777605efdf

> FDA 483 for Daniel H. Ahn D.O. on September 22, 2023. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Daniel H. Ahn D.O.
- Inspection Date: 2023-09-22
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: During an inspection from September 18-22, 2023, the FDA issued a Form 483 to Daniel H. Ahn D.O., a clinical investigator in Phoenix, AZ. The inspection revealed a significant deviation from protocol, as the clinical investigation was not conducted in accordance with the signed statement of investigator and investigational plan. This included failures to complete required ECGs and Hematology/Chemistry labs for multiple subjects across various cycles.

## Related Officers

- [Habacuc V. Barrera](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)
- [Jasmine Y. Wang](https://www.keypedia.com/people/jasmine-y-wang/e23c7335-477c-4671-8dcc-72e9149d424e)

Company: https://www.keypedia.com/companies/daniel-h-ahn-do/b17c8334-4e9b-4c2e-8c9c-1896e405bcce

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab